barcelona . spain - European Association for the Study of the Liver

BARCELONA . SPAIN
74 POSTGRADUATE COURSE SYLLABUS ALCOHOLIC LIVER DISEASE 75
APRIL 18 - 19/2012 THE INTERNATIONAL LIVER CONGRESS TM 2012
REFERENCES
Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient
elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population
aged over 45 years. GUT 2011;60:977-984.
Hock B SM, Domke I, Grunert VP, Wuertemberger M, Schiemann U, Horster S, Limmer
C, Stecker G, Soyka M. Validity of carbohydrate-deficient transferrin (%CDT), gammaglutamyltransferase
(gamma-GT) and mean corpuscular erythrocyte volume (MCV) as
biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver
disorders of non-alcoholic and alcoholic origin. Addiction 2005;100:1477-1486.
Bell H TC, Try K, Haug E. Carbohydrate-deficient transferrin and other markers of high alcohol
consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol
Clin Exp Res 1994;18:1103-1108.
Seitz HK. Additive effects of moderate drinking and obesity on serum gamma-glutamyl
transferase. Am J Clin Nutr 2006;83:1252-1253.
Ferenci P, Dragosics B, Pesendorfer FX, Schubert H. [Gamma-glutamyl-transpeptidase in
alcoholic liver diseases]. Acta Med Austriaca 1976;3:50-54.
Cohen JA, Kaplan MM. The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci
1979;24:835-838.
Helander A, Tabakoff B. Biochemical markers of alcohol use and abuse: experiences from
the Pilot Study of the WHO/ISBRA Collaborative Project on state and trait markers of alcohol.
International Society for Biomedical Research on Alcoholism. Alcohol Alcohol 1997;32:133-144.
Zoli M, Cordiani MR, Marchesini G, Iervese T, Labate AM, Bonazzi C, et al. Prognostic indicators
in compensated cirrhosis. Am J Gastroenterol 1991;86:1508-1513.
Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP):
A novel tool for the non-invasive evaluation of steatosis using Fibroscan((R)). Clin Res Hepatol
Gastroenterol 2011.
d’Assignies G RM, Khiat A, Lepanto L, Chagnon M, Kauffmann C, et al. Noninvasive quantitation
of human liver steatosis using magnetic resonance and bioassay methods Eur Radiol 2009;19
2033-2040.
Mancini M PA, Annuzzi G, Liuzzi R, Giacco R, Medagli C, Cremone M, Clemente G, Maurea S,
Riccardi G, Rivellese AA, Salvatore M. Sonographic hepatic-renal ratio as indicator of hepatic
steatosis: comparison with (1)H magnetic resonance spectroscopy. Metabolism
2009;58:1724-1730.
Ratziu V BS, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based
on the EASL 2009 special conference. J Hepatol 2010;53:372-384.
Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease Hepatic
Medicine: Evidence and Research 2010;2:49-67.
Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int 2011;
5:625-634.
Naveau S GG, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prevot S, Ngo Y,
Munteanu M, Balian A, Njike-Nakseu M, Perlemuter G, Poynard T. Diagnostic and prognostic
values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
Hepatology 2009;49:97-105.
Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, et al. Assessment
of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with
seven non-invasive laboratory tests. Aliment Pharmacol Ther 2008;28:1188-1198.
Rosenberg WM VM, Thiel R. Becka M, Burt A, Schuppan D, Hubscher S, Roskams
T, Pinzani M, Arthur MJ. Serum markers detect the presence of liver fibrosis: a cohort study.
Gastroenterology 2004;127:1704-1713.
Lieber CS WD, Morgan TR, Paronetto F. Aspartate aminotransferase to platelet ratio index
in patients with alcoholic liver fibrosis. Am J Gastroenterol 2006;101:1500-1508.
Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers
of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:
1069-1075.
Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, et al. Biomarkers for
the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol
Hepatol 2005;3:167-174.
Cales P OF, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, Gallois Y, Ternisien C,
Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis.
Hepatology 2005;42:1373-1181.
Parkes J RP, Harris S, Day C, Mutimer D, Collier J, Lombard M, Alexander G, Ramage J,
Dusheiko G, Wheatley M, Gough C, Burt A, Rosenberg W. Enhanced liver fibrosis test can
predict clinical outcomes in patients with chronic liver disease. GUT 2010;59:1245-1251.
Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography:
a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol
2003;29:1705-1713.
Castera L PM. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take
two to tango GUT 2010;59:861-866.
Boursier J, Konate A, Guilluy M, Gorea G, Sawadogo A, Quemener E, et al. Learning curve and
interobserver reproducibility evaluation of liver stiffness measurement by transient elastography.
Eur J Gastroenterol Hepatol 2008;20:693-701.
Kazemi F, Kettaneh A, N’Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness
measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J
Hepatol 2006;45:230-235.
Castera L, Bail BL, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, et al. Early
detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C:
Comparison of transient elastography (FibroScan) with standard laboratory tests and noninvasive
scores. J Hepatol 2009;50:59-68.
Janssens F, de Suray N, Piessevaux H, Horsmans Y, de Timary P, Starkel P. Can Transient
Elastography Replace Liver Histology for Determination of Advanced Fibrosis in Alcoholic
Patients: A Real-life Study. J Clin Gastroenterol.
Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver
stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J
Gastroenterol 2010;16:966-972.
Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Ledinghen V, Douvin C, et al. Assessment
of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol
2008;49:1062-1068.
Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver
stiffness values measured by transient elastography. Hepatology 2008;47:380-384.
Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of
cirrhosis in patients with acute liver damage. Hepatology 2008;47:592-595.
Lanzi A, Gianstefani A, Mirarchi MG, Pini P, Conti F, Bolondi L. Liver AL amyloidosis as a possible
cause of high liver stiffness values. Eur J Gastroenterol Hepatol 2009.
Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly
influenced by central venous pressure. J Hepatol 2010;52:206-210.
Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic
cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48:
1718-1723.
Gelsi E, Dainese R, Truchi R, Marine-Barjoan E, Anty R, Autuori M, et al. Effect of detoxification
on liver stiffness assessed by fibroscan((R)) in alcoholic patients. Alcohol Clin Exp
Res 2011;35:566-570.